Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase

scientific article

Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BCP.2009.07.023
P698PubMed publication ID19665452
P5875ResearchGate publication ID26727332

P50authorAristi P. FernandesQ37610348
Maria Pia RigobelloQ47136370
Valentina GandinQ57033119
Cristina MarzanoQ60971087
Francesco TisatoQ88611404
Alberto BindoliQ115160275
Francesca SorrentinoQ115160324
Mikael BjörnstedtQ115160326
P2093author name stringAlberto Sturaro
Rocco Rella
Barbara Dani
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectcell deathQ2383867
P304page(s)90-101
P577publication date2009-08-07
P1433published inBiochemical PharmacologyQ864229
P1476titleCancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase
P478volume79

Reverse relations

cites work (P2860)
Q89598952A Novel Assay Method to Determine the β-Elimination of Se-Methylselenocysteine to Monomethylselenol by Kynurenine Aminotransferase 1
Q42239873A triclinic polymorph of tri-cyclo-hexyl-phosphane sulfide: crystal structure and Hirshfeld surface analysis
Q40651065Activity of phosphino palladium(II) and platinum(II) complexes against HIV-1 and Mycobacterium tuberculosis
Q34931100Alteration of thioredoxin reductase 1 levels in elucidating cancer etiology
Q37833099Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Q38917659Antioxidant enzyme inhibitor role of phosphine metal complexes in lung and leukemia cell lines.
Q34049230Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells
Q36546701Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer
Q34231446Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia
Q33829292Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Q34774888Auranofin, an anti-rheumatic gold compound, modulates apoptosis by elevating the intracellular calcium concentration ([ca2+]I) in mcf-7 breast cancer cells.
Q36772192Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells
Q37745339Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer
Q50479237Developmental toxicity of auranofin in zebrafish embryos
Q41281464Differential expression of disulfide reductase enzymes in a free-living platyhelminth (Dugesia dorotocephala).
Q37001194Drug Repurposing for Gastrointestinal Stromal Tumor
Q35060920Effect of 2-chloro-substitution of adenine moiety in mixed-ligand gold(I) triphenylphosphine complexes on anti-inflammatory activity: the discrepancy between the in vivo and in vitro models
Q28579069Effects of hyperoxia on cytoplasmic thioredoxin system in alveolar type epithelial cells of premature rats
Q39457061Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression.
Q47712025Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes.
Q39746460Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study
Q35682793Exposure to silver nanoparticles inhibits selenoprotein synthesis and the activity of thioredoxin reductase
Q49789150Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma
Q92724049Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment
Q28243207Gold compounds as therapeutic agents for human diseases
Q28543014Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activities
Q39493102Gold(i) complexes of water-soluble diphos-type ligands: Synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition
Q89069255Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?
Q33951227Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration
Q47652117Historical and biochemical aspects of a seventeenth century gold-based aurum vitae recipe
Q36376153Human Serum Albumin-Delivered [Au(PEt3)]+ Is a Potent Inhibitor of T Cell Proliferation
Q39185517Human cancerous and healthy cell cytotoxicity studies of a chiral μ-dicarbene-digold(I) metallamacrocycle
Q28533669Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugs
Q35446994Iminophosphorane-organogold(III) complexes induce cell death through mitochondrial ROS production
Q30920586Impedance technology reveals correlations between cytotoxicity and lipophilicity of mono and bimetallic phosphine complexes
Q31148784In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles.
Q55429885In vitro antineoplastic effects of auranofin in canine lymphoma cells.
Q90264057Iron (II) Polypyridyl Complexes as Antiglioblastoma Agents to Overcome the Blood-Brain Barrier and Inhibit Cell Proliferation by Regulating p53 and 4E-BP1 Pathways
Q37709144Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
Q35448162Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease
Q36021556Luminescent Di‐ and Polynuclear Organometallic Gold(I)–Metal (Au2, {Au2Ag}n and {Au2Cu}n) Compounds Containing Bidentate Phosphanes as Active Antimicrobial Agents
Q39049711Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity
Q90678045Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response
Q33805225Metal complexes as potential modulators of inflammatory and autoimmune responses
Q26800031Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer Agents
Q98200506Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivo
Q43153890Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin.
Q38718171Mononuclear gold(iii) complexes with l-histidine-containing dipeptides: tuning the structural and biological properties by variation of the N-terminal amino acid and counter anion.
Q39113331Ni(II) and Cu(II) N(4)-ethylmorpholine citronellalthiosemicarbazonate: a comparative analysis of cytotoxic effects in malignant human cancer cell lines
Q61958115Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma
Q38796911Novel antitumor adamantane-azole gold(I) complexes as potential inhibitors of thioredoxin reductase.
Q91690519Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment
Q92080320Pentathiepins: a novel class of glutathione peroxidase 1 inhibitors that induce oxidative stress, loss of mitochondrial membrane potential and apoptosis in human cancer cells
Q92493928Pharmacokinetics and Tissue Distribution of a Novel Bis-Chelated Gold(I) Diphosphine Compound, Bis(2,3-bis(tert-butylmethylphosphino)Quinoxaline)Aurate(I), in Rats
Q37714208Phosphinogold(I) dithiocarbamate complexes: effect of the nature of phosphine ligand on anticancer properties
Q90929522ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin
Q36140846Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells.
Q46894751Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase
Q42116442Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs
Q64055412Studies on the Interaction between Poly-Phosphane Gold(I) Complexes and Dihydrofolate Reductase: An Interplay with Nicotinamide Adenine Dinucleotide Cofactor
Q39495236Studies on the cytotoxic, apoptotic and antitumoral effects of Au(III) and Pt(II) complexes of 1, 10-phenanthroline on V79 379A and A549 cell lines
Q38755076Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells
Q39385088Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents
Q52893904Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes.
Q38897130Synthesis, reactivity, and biological activity of gold(I) complexes modified with thiourea-functionalized tyrosine kinase inhibitors
Q37808628Targeting selenium metabolism and selenoproteins: novel avenues for drug discovery
Q40229976The Enzymatic and Structural Basis for Inhibition of Echinococcus granulosus Thioredoxin Glutathione Reductase by Gold(I).
Q39126478The influence of R substituents in triphenylphosphinegold(I) carbonimidothioates, Ph3PAu[SC(OR)=NPh] (R=Me, Et and iPr), upon in vitro cytotoxicity against the HT-29 colon cancer cell line and upon apoptotic pathways
Q39111089The relationship between electrospray ionization behavior and cytotoxic activity of [M(I)(P)4](+)-type complexes (M = Cu, Ag and Au; P = tertiary phosphine).
Q36430099Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism
Q50686302Toxicity assessment of 7 anticancer compounds in zebrafish
Q89870257Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions

Search more.